CDSCO flags 39 drug samples including Aspirin, Remdesivir as not of standard quality Medical Dialogues Team31 July 2021 7:15 AM GMTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO) has flagged 39 medic...
Present clinical trial, pharmacokinetic data of antiparasitic drug Tafenoquine: CDSCO panel tells GSK Medical Dialogues Team31 July 2021 5:00 AM GMTNew Delhi: Seeking justification for Phase III Clinical Trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Org...
Sun Pharma secures CDSCO panel okay for Amantadine ER Tablets to treat Parkinson Medical Dialogues Team30 July 2021 7:05 AM GMTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organizat...
NPPA panel fixes price of Dapagliflozin, Metformin FDC marketed by Lupin Medical Dialogues Team29 July 2021 12:51 PM GMTNew Delhi: With the popular antidiabetic drug, Dapagliflozin, going off-patent, the National Pharmaceutical Pricing Authority (NPPA) panel, giving bene...
DCGI classifies 36 cardiovascular medical devices, Details Medical Dialogues Team29 July 2021 4:00 AM GMTNew Delhi: Based on the intended use, risk associated with the device, and other parameters specified in the First Schedule of the Medical Devices Rule...
NPPA has fixed ceiling prices of 355 medicines, 882 formulations: Minister tells Parliament Medical Dialogues Team28 July 2021 10:11 AM GMTNew Delhi: The National Pharmaceutical Pricing Authority has fixed the ceiling prices of 355 medicines and 882 formulations for medicines under Nationa...
Withdraw marketing of Durvalumab for metastatic urothelial carcinoma: CDSCO panel tells AstraZeneca Medical Dialogues Team27 July 2021 12:13 PM GMTNew Delhi: In a major setback to AstraZeneca Pharma India Limited., the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organ...
Setback to AstraZeneca: Delhi HC rejects plea against 9 pharma firms over Dapagliflozin Medical Dialogues Team26 July 2021 10:42 AM GMTNew Delhi: In a major setback to AstraZeneca and its Indian subsidiary ,the Delhi High Court has dismissed AstraZeneca's plea against nine generic phar...
Already approved drugs with changes in active substance may be considered as new drug: DCGI Medical Dialogues Team26 July 2021 4:30 AM GMTNew Delhi: The apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has clarified that any changes in polymorphs/cr...
Include more Govt sites in Dapagliflozin, Teneligliptin FDC phase 3 trial: CDSCO panel tells Macleods Pharma Medical Dialogues Team25 July 2021 5:45 AM GMTNew Delhi: Macleods Pharmaceutical has recently received permission from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organ...
NPPA revises MRP of 5 Medical devices commonly used in Covid management Medical Dialogues Team24 July 2021 12:53 PM GMTNew Delhi: With an aim to regulate the prices of medical devices, essential for diagnostic purposes, in general and specifically for COVID-19 managemen...
Sun Pharma cancer drug Pemetrexed Solution for Infusion gets CDSCO panel okay Medical Dialogues Team23 July 2021 12:53 PM GMTNew Delhi: Pharmaceutical major, Sun Pharma, has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organizat...
